Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8895544 Indazoles

Patent 8895544 was granted and assigned to Pfizer Limited on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88955440

Patent Inventor Names

Steven Wade Korturn0

Florian Michel Wakenhut0

Gavin Alistair Whitlock0

Jotham Wadsworth Coe0

Peter Jones0

Christoph Martin Dehnhardt0

Yogesh Anil Sabnis0

Date of Patent

November 25, 2014

Patent Application Number

140413870

Date Filed

September 30, 2013

Patent Citations Received

‌

US Patent 12122773 Crystalline hydrate of a JAK inhibitor compound

‌

US Patent 11667637 Fused imidazo-piperidine JAK inhibitors

‌

US Patent 11702415 Crystalline hydrate of a JAK inhibitor compound

‌

US Patent 11713315 5 to 7 membered heterocyclic amides as JAK inhibitors

‌

US Patent 11786517 Methods of treatment using a JAK inhibitor compound

‌

US Patent 11878977 JAK inhibitors containing a 4-membered heterocyclic amide

Patent Primary Examiner

‌

Janet L. Andres

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8895544 Indazoles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API